Development and provision of pharmaceutical products and therapies for various medical conditions.
C
CSR Analysis score
The organization is among the 50% most committed organizations, excluding the top 20%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: March 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Octapharma France
B
Development and distribution of therapeutic pharmaceutical products for healthcare professionals and patients.
Biocodex
B
Development and provision of pharmaceutical solutions focusing on microbiota care, women's health, and orphan diseases.
MicroPort
B
Development and provision of innovative medical devices and technical solutions to improve patient care globally.
Initiatives identified among leaders
Résultats tangibles de la stratégie de décarbonation
“Biocodex a obtenu des résultats tangibles dans sa ...” - BiocodexDéfinition d'indicateurs de performance pour la gouvernance
“MicroPort définit des indicateurs de performance p...” - MicroPortEngagement RSE structuré selon normes internationales pour intégrité et pérennité
“Octapharma s’engage à intégrer une démarche de res...” - Octapharma France68% of similar organizations communicate on CSR issues
+2279 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports